Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | TDP2 | O95551 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | GALK1 | P51570 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL458928 | 0.74 | SLC22A12 (0.39) | KDM4EMEN1MAPTKMT2AAPAF1 | |
| SCHEMBL616045 | 0.74 | SLC22A12 (0.39) | KDM4EMEN1MAPTKMT2AAPAF1 | |
| SCHEMBL5484988 | 0.70 | POLB (0.42) | MAPTKMT2APOLBAPEX1AKR1C3 | |
| SCHEMBL30528 | 0.68 | CYP2C9 (0.51) | MEN1MAPTKMT2ACYP2C9ALDH1A1 | |
| SCHEMBL30530 | 0.68 | CYP2C9 (0.51) | MEN1MAPTKMT2ACYP2C9ALDH1A1 | |
| SCHEMBL15732949 | 0.67 | KMT2A (0.49) | KMT2ASLC22A12SLC2A9APEX1AKR1C3 | |
| SCHEMBL19097598 | 0.67 | KMT2A (0.49) | KMT2ASLC22A12SLC2A9APEX1AKR1C3 | |
| Iodide SCHEMBL3761279 | 0.67 | CYP2C9 (0.50) | MEN1MAPTKMT2ACYP2C9ALDH1A1 | |
| SCHEMBL9960569 | 0.65 | APEX1 (0.50) | POLBCYP2C9APEX1AKR1C3 | |
| SCHEMBL6736212 | 0.64 | CYP2C9 (0.47) | MEN1MAPTKMT2ACYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1296697-A4 | THERAPEUTIC AGENTS - I | PEPLIN RESEARCH PTY LTD (AU) | 2005-02-16 | — | — | EP | claimed |
| EP-1296698-A4 | THERAPEUTIC AGENTS - II | PEPLIN RESEARCH PTY LTD (AU) | 2005-02-16 | — | — | EP | claimed |
| EP-1320376-A2 | TREATMENT OF PROSTATE CANCER | Peplin Research Pty Ltd (AU) | 2003-06-25 | — | — | EP | claimed |
| EP-1296697-A1 | THERAPEUTIC AGENTS - I | Peplin Research Pty Ltd (AU) | 2003-04-02 | — | — | EP | claimed |
| EP-1296698-A1 | THERAPEUTIC AGENTS - II | Peplin Research Pty Ltd (AU) | 2003-04-02 | — | — | EP | claimed |
| WO-2002011743-A2 | TREATMENT OF PROSTATE CANCER | PEPLIN RESEARCH PTY LTD (AU) | 2002-02-14 | — | — | WO | claimed |
| WO-2001093884-A1 | THERAPEUTIC AGENTS - I | PEPLIN RESEARCH PTY. LTD. (AU) | 2001-12-13 | — | — | WO | claimed |
| WO-2001093885-A1 | THERAPEUTIC AGENTS - II | PEPLIN RESEARCH PTY LTD (AU) | 2001-12-13 | — | — | WO | claimed |
| EP-3007676-A1 | A TOPICAL COMPOSITION | Leo Laboratories Limited (IE) | 2016-04-20 | — | — | EP | disclosed |
| WO-2014198807-A1 | A TOPICAL COMPOSITION | LEO LABORATORIES LIMITED (IE) | 2014-12-18 | — | — | WO | disclosed |
| EP-1965818-A1 | METHODS FOR WOUND HEALING | Peplin Research Pty Ltd. (AU) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007059584-A1 | METHODS FOR WOUND HEALING | PEPLIN RESEARCH PTY LTD (AU) | 2007-05-31 | — | — | WO | disclosed |
| EP-1296698-A4 | THERAPEUTIC AGENTS - II | PEPLIN RESEARCH PTY LTD (AU) | 2005-02-16 | — | — | EP | disclosed |
| EP-1296697-A4 | THERAPEUTIC AGENTS - I | PEPLIN RESEARCH PTY LTD (AU) | 2005-02-16 | — | — | EP | disclosed |
| EP-1296698-A1 | THERAPEUTIC AGENTS - II | Peplin Research Pty Ltd (AU) | 2003-04-02 | — | — | EP | disclosed |
| EP-1296697-A1 | THERAPEUTIC AGENTS - I | Peplin Research Pty Ltd (AU) | 2003-04-02 | — | — | EP | disclosed |
| EP-1296699-A1 | THERAPEUTIC AGENTS - III | Peplin Research Pty Ltd (AU) | 2003-04-02 | — | — | EP | disclosed |
| WO-2001093884-A1 | THERAPEUTIC AGENTS - I | PEPLIN RESEARCH PTY. LTD. (AU) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001093883-A1 | THERAPEUTIC AGENTS - III | PEPLIN RESEARCH PTY LTD (AU) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001093885-A1 | THERAPEUTIC AGENTS - II | PEPLIN RESEARCH PTY LTD (AU) | 2001-12-13 | — | — | WO | disclosed |